Drug Profile
SKP 818
Alternative Names: KR 30818Latest Information Update: 26 Mar 2008
Price :
$50
*
At a glance
- Originator Korea Research Institute of Chemical Technology
- Developer SK Pharma
- Class Benzopyrans; Pyrrolidinones; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial ischaemia
Most Recent Events
- 04 Jun 1998 Investigation in Myocardial ischaemia in South Korea (Unknown route)
- 07 Apr 1998 A preclinical study has been added to the pharmacokinetics and the Ischaemic Heart Disease pharmacodynamics sections
- 20 Nov 1996 Preclinical development for Myocardial ischaemia in South Korea (Unknown route)